ArticlePloS one2026

Comparative safety of imeglimin versus sitagliptin in Japanese patients with type 2 diabetes: A pharmacy-based retrospective cohort study.

Nao Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.